Literature DB >> 4567104

Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.

H W Ward.   

Abstract

Entities:  

Keywords:  Breast Cancer; Cancer; Clinical Research; Diseases; Family Planning; Fertility Agents; Hormone Antagonists; Neoplasms; Reproductive Control Agents; Research Methodology; Tamoxifen--side effects; Tamoxifen--therapeutic use

Mesh：

Substances：

Year:  1973        PMID： 4567104      PMCID： PMC1588574          DOI： 10.1136/bmj.1.5844.13

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  CLOMIPHENE CITRATE (NSC-35770) IN DISSEMINATED MAMMARY CARCINOMA.

Authors:  A L HERBST; C T GRIFFITHS; R W KISTNER
Journal:  Cancer Chemother Rep       Date:  1964-12

2.  Observations on the use of a non-steroidal estrogen antagonist: MER-25.

Authors:  R W KISTNER; O W SMITH
Journal:  Surg Forum       Date:  1960

3.  A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.

Authors:  M P Cole; C T Jones; I D Todd
Journal:  Br J Cancer       Date:  1971-06       Impact factor: 7.640
  3 in total
  79 in total

Review 1.  Manganese superoxide dismutase: beyond life and death.

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Yong Xu; Daret K St Clair
Journal:  Amino Acids       Date:  2010-05-08       Impact factor: 3.520

Review 2.  Metastatic breast cancer: The Odyssey of personalization.

Authors:  A Sonnenblick; N Pondé; M Piccart
Journal:  Mol Oncol       Date:  2016-07-11       Impact factor: 6.603

Review 3.  The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors:  D A Tonetti; V C Jordan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

Review 4.  Estrogen and progesterone receptors: from molecular structures to clinical targets.

Authors:  Stephan Ellmann; Heinrich Sticht; Falk Thiel; Matthias W Beckmann; Reiner Strick; Pamela L Strissel
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

5.  Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung.

Authors:  D Fairlamb; E Boesen
Journal:  Postgrad Med J       Date:  1977-05       Impact factor: 2.401

6.  Tamoxifen in the management of metastatic cancer of the breast.

Authors:  L A Cone; N E Romanoff; N A Helm
Journal:  West J Med       Date:  1979-09

Review 7.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

8.  In search of novel drug target sites on estrogen receptors using RNA aptamers.

Authors:  Daiying Xu; Vamsee-Krishna Chatakonda; Antonis Kourtidis; Douglas S Conklin; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2014-03-03       Impact factor: 5.486

Review 9.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 10.  Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.

Authors:  Christa K Baumann; Monica Castiglione-Gertsch
Journal:  Drugs       Date:  2007       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.